Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom’s Macroglobulinemia after BNT162b2 Booster Vaccination

Low Spike Antibody Levels and Impaired BA.4/5 Neutralization in Patients with Multiple Myeloma or Waldenstrom’s Macroglobulinemia after BNT162b2 Booster Vaccination

Patients with symptomatic monoclonal gammopathies have impaired humoral responses to COVID-19 vaccination. Their ability to recognize SARS-CoV-2 Omicron variants is of concern. We compared the response to BNT162b2 mRNA vaccinations of patients with multiple myeloma (MM, n = 60) or Waldenstrom’s macr...

Full description

Bibliographic Details
Main Authors: Margherita Rosati, Evangelos Terpos, Jenifer Bear, Robert Burns, Santhi Devasundaram, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios-Athanasios Dimopoulos, George N. Pavlakis, Barbara K. Felber
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
COVID vaccine
multiple myeloma
Waldenstrom’s macroglobulinemia
neutralization
WA1
BA.1
Online Access:https://www.mdpi.com/2072-6694/14/23/5816

Internet

https://www.mdpi.com/2072-6694/14/23/5816

Similar Items